Ubs Asset Management Americas Inc Agios Pharmaceuticals, Inc. Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 113,229 shares of AGIO stock, worth $6.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

113,229

Previous 125,470 9.76%

Holding current value

$6.09 Million

Previous $5.41 Million 7.02%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$41.19 - $49.72 $504,206 - $608,622	-12,241 Reduced 9.76%	113,229 $5.03 Million
Q2 2024 Aug 13, 2024	BUY	$27.55 - $48.83 $2.15 Million - $3.81 Million	78,009 Added 164.36%	125,470 $5.41 Million
Q3 2023 Nov 13, 2023	SELL	$24.36 - $28.18 $4.95 Million - $5.72 Million	-203,073 Reduced 81.06%	47,461 $1.17 Million
Q1 2023 May 15, 2023	SELL	$21.74 - $30.93 $3.41 Million - $4.85 Million	-156,775 Reduced 38.49%	250,534 $5.75 Million
Q4 2022 Feb 14, 2023	SELL	$24.81 - $31.52 $1.29 Million - $1.64 Million	-52,036 Reduced 11.33%	407,309 $11.4 Million
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $325,192 - $569,045	-16,668 Reduced 3.5%	459,345 $13 Million
Q2 2022 Aug 12, 2022	BUY	$17.06 - $31.42 $7.02 Million - $12.9 Million	411,312 Added 635.71%	476,013 $10.6 Million
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $45,139 - $75,964	-1,526 Reduced 2.3%	64,701 $2.13 Million
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $254,328 - $352,978	-6,067 Reduced 8.39%	66,227 $3.06 Million
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $1.2 Million - $1.41 Million	-23,041 Reduced 24.17%	72,294 $3.98 Million
Q1 2021 May 14, 2021	BUY	$44.23 - $57.5 $164,491 - $213,842	3,719 Added 4.06%	95,335 $4.92 Million
Q4 2020 Mar 01, 2021	BUY	$33.21 - $46.54 $502,168 - $703,731	15,121 Added 19.77%	91,616 $3.97 Million
Q3 2020 Nov 13, 2020	SELL	$33.87 - $55.93 $55,038 - $90,886	-1,625 Reduced 2.08%	76,495 $2.68 Million
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $12.8 Million - $19.9 Million	-371,707 Reduced 82.63%	78,120 $4.18 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $947,333 - $1.62 Million	-30,055 Reduced 6.26%	449,827 $16 Million
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $2.62 Million - $4.41 Million	87,262 Added 22.23%	479,882 $22.9 Million
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $287,452 - $439,873	8,872 Added 2.31%	392,620 $12.7 Million
Q2 2019 Aug 15, 2019	BUY	$46.17 - $68.1 $4.37 Million - $6.45 Million	94,654 Added 32.74%	383,748 $0
Q1 2019 May 14, 2019	SELL	$45.92 - $67.67 $174,955 - $257,822	-3,810 Reduced 1.3%	289,094 $0
Q4 2018 Feb 13, 2019	BUY	$42.73 - $76.53 $2.24 Million - $4.02 Million	52,486 Added 21.83%	292,904 $13.5 Million
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $2.9 Million - $3.72 Million	-40,492 Reduced 14.41%	240,418 $0
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $3.21 Million - $4.36 Million	-43,842 Reduced 13.5%	280,910 $0
Q1 2018 May 14, 2018	SELL	$59.83 - $86.53 $1.23 Million - $1.78 Million	-20,532 Reduced 5.95%	324,752 $0
Q4 2017 Feb 09, 2018	BUY	$52.12 - $72.33 $16.3 Million - $22.6 Million	312,878 Added 965.49%	345,284 $0
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $1.78 Million - $2.18 Million	32,406	32,406 $0

Others Institutions Holding AGIO

# of Institutions

234

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.95B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Agios Pharmaceuticals, Inc. Transaction History